Please enable JavaScript to continue using this application.

Compare $EVMN vs $TRDA | Chartloom

Compare

$EVMN vs $TRDA

Evommune Inc · Entrada Therapeutics Inc

EVMN

Evommune Inc

TRDA

Entrada Therapeutics Inc

Compare $EVMN vs $TRDA

Comparing Evommune Inc and Entrada Therapeutics Inc

EVMNEvommune Inc

TRDAEntrada Therapeutics Inc

EVMNEvommune Inc

Market cap

$225M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.9%

52W performance

-69.1%

FCF yield

-55.4%

TRDAEntrada Therapeutics Inc

Market cap

$220M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.15x

Rev growth (TTM)

-94.1%

YTD performance

-43.6%

52W performance

-8.0%

FCF yield

-61.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

EVMN

TRDA

Detailed metrics comparison

EVMN

Evommune Inc

TRDA

Entrada Therapeutics Inc

Market Cap

EVMN$225M

TRDA$220M

Enterprise Value

EVMN$166M

TRDA$121M

Price

EVMN$6.25

TRDA$5.67

P/E Ratio

EVMNN/A

TRDAN/A

P/S Ratio

EVMN14.07x

TRDA46.97x

EV/Sales

EVMN10.38x

TRDA25.79x

EV/EBITDA

EVMN0.00x

TRDA15.47x

P/B Ratio

EVMN0.90x

TRDA0.90x

P/FCF Ratio

EVMNN/A

TRDAN/A

EV/FCF

EVMN-1.33x

TRDA-0.89x

PEG Ratio

EVMNN/A

TRDAN/A

Forward P/E (NTM)

EVMNN/A

TRDAN/A

Forward P/S (NTM)

EVMNN/A

TRDA5.15x

Revenue (TTM)

EVMN$16M

TRDA$5M

Revenue Growth (YoY)

EVMNN/A

TRDA-94.1%

Forward Rev Growth

EVMN881.5%

TRDA124.9%

Gross Margin (TTM)

EVMN0.0%

TRDA0.0%

Operating Margin (TTM)

EVMN0.0%

TRDA0.0%

EBITDA Margin (TTM)

EVMN-1097.9%

TRDA-3686.8%

Net Margin (TTM)

EVMN-943.2%

TRDA-3537.7%

FCF Margin (TTM)

EVMN-779.8%

TRDA-2883.2%

Net Income (TTM)

EVMN$-151M

TRDA$-166M

FCF (TTM)

EVMN$-125M

TRDA$-135M

EPS (TTM)

EVMN-$4.18

TRDA-$3.93

ROE (TTM)

EVMN-4676.0%

TRDA-5761.0%

ROA (TTM)

EVMN-4337.0%

TRDA-4654.0%

ROIC (TTM)

EVMN-4661.0%

TRDA-5761.0%

Cash

EVMN$60M

TRDA$99M

Debt

EVMN$952K

TRDA$0

Net Cash/Debt

EVMN$59M

TRDA$99M

Current Ratio (TTM)

EVMN11.68x

TRDA10.89x

Quick Ratio (TTM)

EVMN11.48x

TRDA10.47x

Debt/Equity (TTM)

EVMN0.00x

TRDA0.00x

Debt/Assets (TTM)

EVMN0.0%

TRDA0.0%

Interest Coverage (TTM)

EVMNN/A

TRDAN/A

Net Debt/EBITDA (TTM)

EVMN0.00x

TRDA0.00x

Beta

EVMN0.62

TRDA-0.22

52W Performance

EVMN-69.1%

TRDA-8.0%

YTD Performance

EVMN-63.9%

TRDA-43.6%

% from 52W High

EVMN-81.2%

TRDA-65.5%

% from 52W Low

EVMN3.8%

TRDA10.1%

Asset Turnover (TTM)

EVMN0.00x

TRDA0.01x

FCF Yield (TTM)

EVMN-55.4%

TRDA-61.4%

Earnings Yield (TTM)

EVMN-67.0%

TRDA-75.3%

Dividend Yield (TTM)

EVMNN/A

TRDAN/A

Rule of 40

EVMN-779.8

TRDA-2,977.3

EV/GP/RG

EVMNN/A

TRDAN/A

Ticker research

View EVMN research View TRDA research

Metric	EVMN Evommune Inc	TRDA Entrada Therapeutics Inc
Market & Valuation
Market Cap	$225M	$220M
Enterprise Value	$166M	$121M
Price	$6.25	$5.67
P/E Ratio	N/A	N/A
P/S Ratio	14.07x	46.97x
EV/Sales	10.38x	25.79x
EV/EBITDA	0.00x	15.47x
P/B Ratio	0.90x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.15x
Revenue & Growth
Revenue (TTM)	$16M	$5M
Revenue Growth (YoY)	N/A	-94.1%
Forward Rev Growth	881.5%	124.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1097.9%	-3686.8%
Net Margin (TTM)	-943.2%	-3537.7%
FCF Margin (TTM)	-779.8%	-2883.2%
Net Income (TTM)	$-151M	$-166M
FCF (TTM)	$-125M	$-135M
EPS (TTM)	-$4.18	-$3.93
ROE (TTM)	-4676.0%	-5761.0%
ROA (TTM)	-4337.0%	-4654.0%
ROIC (TTM)	-4661.0%	-5761.0%
Financial Health
Cash	$60M	$99M
Debt	$952K	$0
Net Cash/Debt	$59M	$99M
Current Ratio (TTM)	11.68x	10.89x
Quick Ratio (TTM)	11.48x	10.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	-0.22
52W Performance	-69.1%	-8.0%
YTD Performance	-63.9%	-43.6%
% from 52W High	-81.2%	-65.5%
% from 52W Low	3.8%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-55.4%	-61.4%
Earnings Yield (TTM)	-67.0%	-75.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-779.8	-2,977.3
EV/GP/RG	N/A	N/A
Ticker research	View EVMN research	View TRDA research

Valuation

P/S Ratio

EVMN

14.07x

TRDA

46.97x

EV/FCF

EVMN

-1.33x

TRDA

-0.89x

Growth & revenue

Revenue Growth TTM

TRDA

-94.1%

Forward Revenue Growth

EVMN

881.5%

TRDA

124.9%

Profitability & performance

Gross Margin

EVMN

0.0%

TRDA

0.0%

ROE

EVMN

-4676.0%

TRDA

-5761.0%

FCF Yield %

EVMN

-55.4%

TRDA

-61.4%

52-Week Performance

TRDA

-8.0%

EVMN

-69.1%

Detailed metrics comparison

EVMN

Evommune Inc

TRDA

Entrada Therapeutics Inc

Market Cap

EVMN$225M

TRDA$220M

Enterprise Value

EVMN$166M

TRDA$121M

Price

EVMN$6.25

TRDA$5.67

P/E Ratio

EVMNN/A

TRDAN/A

P/S Ratio

EVMN14.07x

TRDA46.97x

EV/Sales

EVMN10.38x

TRDA25.79x

EV/EBITDA

EVMN0.00x

TRDA15.47x

P/B Ratio

EVMN0.90x

TRDA0.90x

P/FCF Ratio

EVMNN/A

TRDAN/A

EV/FCF

EVMN-1.33x

TRDA-0.89x

PEG Ratio

EVMNN/A

TRDAN/A

Forward P/E (NTM)

EVMNN/A

TRDAN/A

Forward P/S (NTM)

EVMNN/A

TRDA5.15x

Revenue (TTM)

EVMN$16M

TRDA$5M

Revenue Growth (YoY)

EVMNN/A

TRDA-94.1%

Forward Rev Growth

EVMN881.5%

TRDA124.9%

Gross Margin (TTM)

EVMN0.0%

TRDA0.0%

Operating Margin (TTM)

EVMN0.0%

TRDA0.0%

EBITDA Margin (TTM)

EVMN-1097.9%

TRDA-3686.8%

Net Margin (TTM)

EVMN-943.2%

TRDA-3537.7%

FCF Margin (TTM)

EVMN-779.8%

TRDA-2883.2%

Net Income (TTM)

EVMN$-151M

TRDA$-166M

FCF (TTM)

EVMN$-125M

TRDA$-135M

EPS (TTM)

EVMN-$4.18

TRDA-$3.93

ROE (TTM)

EVMN-4676.0%

TRDA-5761.0%

ROA (TTM)

EVMN-4337.0%

TRDA-4654.0%

ROIC (TTM)

EVMN-4661.0%

TRDA-5761.0%

Cash

EVMN$60M

TRDA$99M

Debt

EVMN$952K

TRDA$0

Net Cash/Debt

EVMN$59M

TRDA$99M

Current Ratio (TTM)

EVMN11.68x

TRDA10.89x

Quick Ratio (TTM)

EVMN11.48x

TRDA10.47x

Debt/Equity (TTM)

EVMN0.00x

TRDA0.00x

Debt/Assets (TTM)

EVMN0.0%

TRDA0.0%

Interest Coverage (TTM)

EVMNN/A

TRDAN/A

Net Debt/EBITDA (TTM)

EVMN0.00x

TRDA0.00x

Beta

EVMN0.62

TRDA-0.22

52W Performance

EVMN-69.1%

TRDA-8.0%

YTD Performance

EVMN-63.9%

TRDA-43.6%

% from 52W High

EVMN-81.2%

TRDA-65.5%

% from 52W Low

EVMN3.8%

TRDA10.1%

Asset Turnover (TTM)

EVMN0.00x

TRDA0.01x

FCF Yield (TTM)

EVMN-55.4%

TRDA-61.4%

Earnings Yield (TTM)

EVMN-67.0%

TRDA-75.3%

Dividend Yield (TTM)

EVMNN/A

TRDAN/A

Rule of 40

EVMN-779.8

TRDA-2,977.3

EV/GP/RG

EVMNN/A

TRDAN/A

Ticker research

View EVMN research View TRDA research

Metric	EVMN Evommune Inc	TRDA Entrada Therapeutics Inc
Market & Valuation
Market Cap	$225M	$220M
Enterprise Value	$166M	$121M
Price	$6.25	$5.67
P/E Ratio	N/A	N/A
P/S Ratio	14.07x	46.97x
EV/Sales	10.38x	25.79x
EV/EBITDA	0.00x	15.47x
P/B Ratio	0.90x	0.90x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.33x	-0.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.15x
Revenue & Growth
Revenue (TTM)	$16M	$5M
Revenue Growth (YoY)	N/A	-94.1%
Forward Rev Growth	881.5%	124.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1097.9%	-3686.8%
Net Margin (TTM)	-943.2%	-3537.7%
FCF Margin (TTM)	-779.8%	-2883.2%
Net Income (TTM)	$-151M	$-166M
FCF (TTM)	$-125M	$-135M
EPS (TTM)	-$4.18	-$3.93
ROE (TTM)	-4676.0%	-5761.0%
ROA (TTM)	-4337.0%	-4654.0%
ROIC (TTM)	-4661.0%	-5761.0%
Financial Health
Cash	$60M	$99M
Debt	$952K	$0
Net Cash/Debt	$59M	$99M
Current Ratio (TTM)	11.68x	10.89x
Quick Ratio (TTM)	11.48x	10.47x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.62	-0.22
52W Performance	-69.1%	-8.0%
YTD Performance	-63.9%	-43.6%
% from 52W High	-81.2%	-65.5%
% from 52W Low	3.8%	10.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-55.4%	-61.4%
Earnings Yield (TTM)	-67.0%	-75.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-779.8	-2,977.3
EV/GP/RG	N/A	N/A
Ticker research	View EVMN research	View TRDA research